Ferric Carboxymaltose Injection
Ferric Carboxymaltose Injection is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Injectafer, Ferric Carboxymaltose. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Ferric Carboxymaltose Injection
- Brand Names
- Injectafer, Ferric Carboxymaltose
- Application Number
- NDA203565
- Sponsor
- American Regent, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- FERRIC CARBOXYMALTOSE
Indications and Usage
1 INDICATIONS AND USAGE Injectafer is indicated for the treatment of: • iron deficiency anemia (IDA) in: adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. adult patients who have non-dialysis dependent chronic kidney disease. • iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity. Injectafer is an iron replacement product indicated for the treatment of: • iron deficiency anemia (IDA) in: adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. ( 1 ) adult patients who have non-dialysis dependent chronic kidney disease. ( 1 ) • iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity. ( 1 )